Our client, a top 5 global pharmaceutical company, was seeking support to develop a strategy to aid them in effectively managing the rollout of a combination product. In addition, they needed their system to support the management of any Adverse Events (AEs) reported on their devices and combination products. Their existing AE reporting process was not only manual, but also paper based. With combination products creating some confusion and over-reporting, coupled with upcoming regulations, this was untenable.
Read our latest case study and learn how we successfully configured Oracle Argus to meet Device and Combination Product Regulatory requirements, simplifying the technology landscape to enable better outcomes for our client while driving informed decisions.
Please complete the form to download the Case Study.